Boston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow BSX
Boston Scientific Corporation (BSX) Shares outstanding
Boston Scientific Corporation's shares outstanding at the end of fiscal 2025 was $1.5B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $1.5B. Over the past ten years it has ranged from $1.3B (fiscal 2015) to $1.5B (fiscal 2025) — the current reading is the highest in ten years. Boston Scientific Corporation ranks 2nd of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $1.5B | 0.58% |
| FY2024 | $1.5B | 1.53% |
| FY2023 | $1.5B | 1.65% |
| FY2022 | $1.4B | 0.41% |
| FY2021 | $1.4B | 1.21% |
| FY2020 | $1.4B | 0.43% |
| FY2019 | $1.4B | 0.66% |
| FY2018 | $1.4B | 0.62% |
| FY2017 | $1.4B | 1.13% |
| FY2016 | $1.4B | 2.68% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $1.5B | (1.35%) |
| Mar 2026 | $1.5B | 0.03% |
| Dec 2025 | $1.5B | (0.07%) |
| Sep 2025 | $1.5B | 0.13% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| ABT Abbott Laboratories compare | $1.7B |
| BSX Boston Scientific Corporation | $1.5B |
| MDT Medtronic PLC compare | $1.3B |
| PHG Koninklijke Philips N.V. compare | $968.6M |
| EW Edwards Lifesciences Corporation compare | $577.6M |
| GEHC GE HealthCare Technologies Inc. compare | $454.0M |
| DXCM DexCom, Inc. compare | $390.1M |
| SYK Stryker Corporation compare | $386.0M |
| STE STERIS plc compare | $97.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on BSX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement